Utah Medical Products, Inc.
Utah Medical Products, Inc. (UTMD) Revenue
Annual & quarterly revenue history · segment & region breakdown
UTMD · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsUtah Medical Products, Inc. trailing twelve-month (TTM) revenue is $0.04B, a decrease of 5.83% year-over-year from $0.04B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.04B | -$0.00B | -5.83% |
| 2024-12-31 | $0.04B | -$0.01B | -18.56% |
| 2023-12-31 | $0.05B | -$0.00B | -3.93% |
| 2022-12-31 | $0.05B | +$0.00B | +6.58% |
| 2021-12-31 | $0.05B | +$0.01B | +16.30% |
| 2020-12-31 | $0.04B | -$0.00B | -10.08% |
| 2019-12-31 | $0.05B | +$0.00B | +11.68% |
| 2018-12-31 | $0.04B | +$0.00B | +1.41% |
| 2017-12-31 | $0.04B | +$0.00B | +5.38% |
| 2016-12-31 | $0.04B | -$0.00B | -2.14% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Utah Medical Products, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Utah Medical Products, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Utah Medical Products, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
UTMD revenue · 4 questionsUTMD's trailing twelve-month (TTM) revenue is $0.04B. That is a decrease of 5.83% year-over-year from $0.04B in FY2025.
▸ Source: FMP · Utah Medical Products, Inc. SEC filings · GAAP · Utah Medical Products, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026